Company Profiles

driven by the PitchBook Platform

Zyngenia

Description

Developer of multi-specific antibody-based drugs in the United States. The company focuses on the development of therapies for various cancers and autoimmune disorders.

2008

Founded

PRIVATE

Status

11-50

Employees

Early Stage VC

Latest Deal Type

$10M

Latest Deal Amount

$40M

Total Amount Raised

Description

Developer of multi-specific antibody-based drugs in the United States. The company focuses on the development of therapies for various cancers and autoimmune disorders.

Website:

www.zyngenia.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Pharmaceuticals

Other Industries

Drug Discovery

Primary Office

P.O. Box 3130 Gaithersburg, MD 20878United States +1 (301) 453-0100
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Zyngenia's full profile, request a free trial.

Zyngenia Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Zyngenia Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Zyngenia Investors (2)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Montgomery County Environmental SolutionsPE/BuyoutMinority000 0000000 0000
New Enterprise AssociatesVenture CapitalMinority000 0000000 0000
Montgomery County Environmental Solutions PE/Buyout
New Enterprise Associates Venture Capital

Zyngenia Executive Team (4)

NameTitleBoard
Seat
Contact
Info
David Hilbert Ph.DChief Scientific Officer & Head, Research & Development
Viktor RoschkeVice President, Biopharmaceutical Research & Assay Development
Carlos Barbas IIIFounder
David Parkinson MDActing Chief Executive Officer & Board Member
David Hilbert Ph.D Chief Scientific Officer & Head, Research & Development
Viktor Roschke Vice President, Biopharmaceutical Research & Assay Development
Carlos Barbas III Founder
David Parkinson MD Acting Chief Executive Officer & Board Member

Zyngenia Board Members (5)

NameRepresentingRoleSinceContact
Info
Christian Itin Ph.DSelfBoard Member000 0000
David MottNew Enterprise AssociatesGeneral Partner000 0000
David Parkinson MDSelfActing Chief Executive Officer & Board Member000 0000
Robert Garland MDNew Enterprise AssociatesVenture Partner000 0000
Sara Nayeem MDNew Enterprise AssociatesPartner000 0000
Christian Itin Ph.D Board Member Self
David Mott General Partner New Enterprise Associates
David Parkinson MD Acting Chief Executive Officer & Board Member Self
Robert Garland MD Venture Partner New Enterprise Associates
Sara Nayeem MD Partner New Enterprise Associates
Request full access to PitchBook